Literature DB >> 23529927

A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease.

Xiao Chen1, Joseph Dodge, Richard Komorowski, William R Drobyski.   

Abstract

Damage to the gastrointestinal tract during graft-versus-host disease (GVHD) is one of the major causes of morbidity and mortality in allogeneic hematopoietic stem cell transplant (HSCT) recipients. In the current study, we identified a critical role for the retinoic acid (RA) signaling pathway in the induction and propagation of gastrointestinal GVHD. The administration of exogenous RA significantly increased expression of the gut-homing molecules, CCR9 and α4β7, on donor T cells in mesenteric lymph nodes, and augmented the accumulation of proinflammatory CD4(+) and CD8(+) T cells within the gut mucosa, leading to a selective exacerbation of colonic GVHD and increased overall mortality. Conversely, depletion of RA in recipient mice by vitamin A deprivation resulted in a dramatic reduction of gut-homing molecule expression on donor T cells after HSCT. Significantly, absence of the RA receptor-α on donor T cells markedly attenuated the ability of these cells to cause lethal GVHD. This observation was attributable to a significant reduction in pathological damage within the colon. These findings identify an organ-specific role for RA in GVHD and provide evidence that blockade of the RA signaling pathway may represent a novel strategy for mitigating the severity of colonic GVHD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529927      PMCID: PMC3650708          DOI: 10.1182/blood-2012-08-445130

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

Review 1.  T-cell function and migration. Two sides of the same coin.

Authors:  U H von Andrian; C R Mackay
Journal:  N Engl J Med       Date:  2000-10-05       Impact factor: 91.245

2.  Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17.

Authors:  Hisakazu Nishimori; Yoshinobu Maeda; Takanori Teshima; Haruko Sugiyama; Koichiro Kobayashi; Yoshiko Yamasuji; Sachiyo Kadohisa; Hidetaka Uryu; Kengo Takeuchi; Takehiro Tanaka; Tadashi Yoshino; Yoichiro Iwakura; Mitsune Tanimoto
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

Review 3.  The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

Authors:  G R Hill; J L Ferrara
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

Review 4.  Oral tolerance.

Authors:  Howard L Weiner; Andre Pires da Cunha; Francisco Quintana; Henry Wu
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

5.  LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

Authors:  K R Cooke; A Gerbitz; J M Crawford; T Teshima; G R Hill; A Tesolin; D P Rossignol; J L Ferrara
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

6.  Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells.

Authors:  Colm B Collins; Carol M Aherne; Douglas Kominsky; Eóin N McNamee; Matthew D P Lebsack; Holger Eltzschig; Paul Jedlicka; Jesús Rivera-Nieves
Journal:  Gastroenterology       Date:  2011-11       Impact factor: 22.682

Review 7.  The role of retinoic acid in tolerance and immunity.

Authors:  Jason A Hall; John R Grainger; Sean P Spencer; Yasmine Belkaid
Journal:  Immunity       Date:  2011-07-22       Impact factor: 31.745

8.  Novel retinoic acid receptor alpha agonists for treatment of kidney disease.

Authors:  Yifei Zhong; Yingwei Wu; Ruijie Liu; Zhengzhe Li; Yibang Chen; Todd Evans; Peter Chuang; Bhaskar Das; John Cijiang He
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

Review 9.  Vitamin A in reproduction and development.

Authors:  Margaret Clagett-Dame; Danielle Knutson
Journal:  Nutrients       Date:  2011-03-29       Impact factor: 5.717

10.  Shift of graft-versus-host-disease target organ tropism by dietary vitamin A.

Authors:  Christian Koenecke; Immo Prinz; Anja Bubke; Alina Schreder; Chun-Wei Lee; Oliver Pabst; Reinhold Förster
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

View more
  18 in total

1.  Treatment with a rho kinase inhibitor improves survival from graft-versus-host disease in mice after MHC-haploidentical hematopoietic cell transplantation.

Authors:  Sujatha Iyengar; Caixin Zhan; Jordan Lu; Robert Korngold; David H Schwartz
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-02       Impact factor: 5.742

2.  Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.

Authors:  Kei Ohnuma; Ryo Hatano; Thomas M Aune; Haruna Otsuka; Satoshi Iwata; Nam H Dang; Taketo Yamada; Chikao Morimoto
Journal:  J Immunol       Date:  2015-03-18       Impact factor: 5.422

3.  Radiation and host retinoic acid signaling promote the induction of gut-homing donor T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Jianwei Zheng; Brian Taylor; Joseph Dodge; Allison Stephans; Song Guo Zheng; Qiang Chen; Xiao Chen
Journal:  Am J Transplant       Date:  2019-07-15       Impact factor: 8.086

4.  Lower levels of vitamin A are associated with increased gastrointestinal graft-versus-host disease in children.

Authors:  Dana T Lounder; Pooja Khandelwal; Christopher E Dandoy; Sonata Jodele; Michael S Grimley; Gregory Wallace; Adam Lane; Cynthia Taggart; Ashley C Teusink-Cross; Kelly E Lake; Stella M Davies
Journal:  Blood       Date:  2017-03-09       Impact factor: 22.113

5.  Kras-Deficient T Cells Attenuate Graft-versus-Host Disease but Retain Graft-versus-Leukemia Activity.

Authors:  Lan Luo; Yuhong Chen; Xiao Chen; Yongwei Zheng; Vivian Zhou; Mei Yu; Robert Burns; Wen Zhu; Guoping Fu; Juan C Felix; Christopher Hartley; Alisa Damnernsawad; Jing Zhang; Renren Wen; Williams R Drobyski; Chunji Gao; Demin Wang
Journal:  J Immunol       Date:  2020-11-06       Impact factor: 5.422

6.  MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease.

Authors:  J-Y Lim; Y-K Lee; S-E Lee; J-M Ju; K-S Eom; Y-J Kim; N-G Chung; D C Jeong; G Park; E Y Choi; C-K Min
Journal:  Mucosal Immunol       Date:  2015-10-07       Impact factor: 7.313

7.  Depletion of host CCR7(+) dendritic cells prevented donor T cell tissue tropism in anti-CD3-conditioned recipients.

Authors:  Wei He; Jeremy J Racine; Heather F Johnston; Xiaofan Li; Nainong Li; Kaniel Cassady; Can Liu; Ruishu Deng; Paul Martin; Stephen Forman; Defu Zeng
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-30       Impact factor: 5.742

8.  Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.

Authors:  Kazutoshi Aoyama; Asim Saha; Jakub Tolar; Megan J Riddle; Rachelle G Veenstra; Patricia A Taylor; Rune Blomhoff; Angela Panoskaltsis-Mortari; Christopher A Klebanoff; Gérard Socié; David H Munn; William J Murphy; Jonathan S Serody; Leshara M Fulton; Takanori Teshima; Roshantha A Chandraratna; Ethan Dmitrovsky; Yanxia Guo; Randolph J Noelle; Bruce R Blazar
Journal:  Blood       Date:  2013-06-27       Impact factor: 22.113

Review 9.  Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia-Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation.

Authors:  Øystein Bruserud; Galina Tsykunova; Maria Hernandez-Valladares; Hakon Reikvam; Tor Henrik Anderson Tvedt
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-02

10.  Graft-versus-host disease propagation depends on increased intestinal epithelial tight junction permeability.

Authors:  Sam C Nalle; Li Zuo; Ma Lora Drizella M Ong; Gurminder Singh; Alicia M Worthylake; Wangsun Choi; Mario Cabrero Manresa; Anna P Southworth; Karen L Edelblum; Gregory J Baker; Nora E Joseph; Peter A Savage; Jerrold R Turner
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.